Follow-The-Filings

Holders · period archive

REGN · Regeneron Pharmaceuticals

Q3 2022 13F holders among managers we track latest ownership dossier

Ticker
REGN
Type
Equity
Class
COM
Total reported value ($000, long equity)
Manager Report date Value Shares